These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 15661050

  • 1. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C, Vesey D, Cotterill A, Douglas M, Gobe G, Nicol D, Johnson D.
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [Abstract] [Full Text] [Related]

  • 2. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
    Chuang ST, Patton KT, Schafernak KT, Papavero V, Lin F, Baxter RC, Teh BT, Yang XJ.
    J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
    [Abstract] [Full Text] [Related]

  • 3. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
    Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M.
    Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
    [Abstract] [Full Text] [Related]

  • 5. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 6. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N, Inoue K, Guo L, Miyazaki E, Hayashi Y, Naruse K, Toi M, Hiroi M, Shuin T, Enzan H.
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [Abstract] [Full Text] [Related]

  • 7. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 8. Expression of vitamin D3 receptor in kidney tumors.
    Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [Abstract] [Full Text] [Related]

  • 9. Ghrelin expression in normal kidney tissue and renal carcinomas.
    Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR.
    Pathol Res Pract; 2009 Oct; 205(3):165-73. PubMed ID: 19054628
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.
    Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ.
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [Abstract] [Full Text] [Related]

  • 12. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
    Hemmerlein B, Johanns U, Halbfass J, Böttcher T, Heuser M, Radzun HJ, Thelen P.
    Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
    [Abstract] [Full Text] [Related]

  • 13. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E, Matoso A, Sabo E, Wang LJ, Tavares R, Meitner P, Morris DJ, Pareek G, Delellis RA, Resnick MB.
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

  • 15. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J, Thiesson H, Walter S, Ottosen PD, Skøtt O, Jensen BL.
    Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.
    Acta Oncol; 2009 Jul; 48(6):909-14. PubMed ID: 19322701
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

  • 18. Expression of insulin-like growth factor binding protein-4, insulin-like growth factor-I receptor, and insulin-like growth factor-I in the mouse uterus throughout the estrous cycle.
    Henemyre C, Markoff E.
    Mol Reprod Dev; 1999 Apr; 52(4):350-9. PubMed ID: 10092114
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER.
    Cancer Res; 2005 Jun 01; 65(11):4598-606. PubMed ID: 15930277
    [Abstract] [Full Text] [Related]

  • 20. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K, Yamamoto H, Taniguchi H, Adachi Y, Yoshida Y, Arimura Y, Endo T, Hinoda Y, Imai K.
    Clin Cancer Res; 2004 Dec 01; 10(23):7950-7. PubMed ID: 15585629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.